Andreas Kuznik News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Andreas kuznik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Andreas Kuznik Today - Breaking & Trending Today
Share this article TARRYTOWN, N.Y., May 19, 2021 /PRNewswire/ Presentations include first positive clinical data for the fianlimab (LAG-3 inhibitor) and Libtayo combination in advanced melanoma Regeneron will host an investor webcast on Monday, June 7 to provide further updates across its oncology portfolio Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the company will share a range of presentations for its PD-1 inhibitor Libtayo ® (cemiplimab-rwlc) and broader oncology portfolio at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting from June 4-8, taking place virtually. Presentations include new clinical data and in-depth analyses on the impact of Libtayo in several advanced cancers, including non-small cell lung cancer (NSCLC), cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC) and melanoma. ....